Superoxide dismutase restores impaired histamine-induced increases in venular macromolecular efflux during diabetes mellitus

Microcirculation

Volumn 5, Issue 2-3, 1998, Pages 211-218

  Mayhan, William G ^a   Sharpe, Glenda M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Nitric oxide; Oxygen radicals; Permeability; Venules

Indexed keywords

DEXTRAN; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; FREE RADICAL; HISTAMINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ACTIVE TRANSPORT; ANIMAL; ARTICLE; CHEEK; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HAMSTER; MACROMOLECULE; METABOLISM; SYRIAN HAMSTER; VASCULARIZATION; VENULE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CHEEK; CRICETINAE; DEXTRANS; DIABETES MELLITUS, EXPERIMENTAL; FLUORESCEIN-5-ISOTHIOCYANATE; FREE RADICALS; HISTAMINE; MACROMOLECULAR SUBSTANCES; MESOCRICETUS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; VENULES;

EID: 0032253468     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1080/mic.5.2-3.211.218     Document Type: Article

References (51)

1. Alsip NL, Schuschke DA, Wead WB, Harris PD. (1992). Alteration of microvascular responses to serotonin in the diabetic rat. Int J Microcirc Clin Exp 11:263-275.
2. Arfors KE, Rutili G, Svensjo E. (1979). Microvascular transport of macromolecules in normal and inflammatory conditions. Acta Physiol Scand 463:93-103.
3. Bohlen HG, Niggl BA. (1979). Arteriolar anatomical and functional abnormalities in juvenile mice with genetic or streptozotocin induced diabetes mellitus. Circ Res 45:390-396.
4. Cohen RA. (1993). Dysfunction of vascular endothelium in diabetes mellitus. Circ 87:V-67-V-76.
5. Colantuoni A, Berardi PG, Orefice G. (1979). Increased permeability of the microcirculation to high molecular weight dextran in experimental diabetes, shown by intravital microfluorimetry. J Nucl Med Allied Sci 23:49-54.
6. Colwell JA, Halushka PV, Sarji KE, Lopes-Virella MF, Sagel J. (1979). Vascular diseases in diabetes: Pathophysiological mechanisms and therapy. Arch Int Med 139:225-230.
7. Corhett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Jr., Williamson JR, McDaniel ML. (1992). Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556.
8. Dai FX, Diederich A, Skopec J, Diederich D. (1993). Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: Role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol 4:1327-1336.
9. Del Maestro RF, Bjork J, Arfors KE. (1981). Increase in microvascular permeability induced by enzymatically generated free radicals. Microvasc Res 22:255-270.
10. Del Maestro RF, Bjork J, Arfors KE. (1981). Increase in microvascular permeability induced by enzymatically generated free radicals. Microvasc Res 22:239-254.
11. Diederich D, Skopec J, Diederich A, Dai FX. (1994). Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: Role of free radicals. Am J Physiol 266:H1153-H1161.
12. Garcia-Leme J, Bohm GM, Migliorini RH, De Souza MZA. (1974). Possible participation of insulin in the control of vascular permeability. Eur J Pharmacol 29: 298-306.
13. Garcia-Leme J, Hamamura L, Migliorini RH, Leite MP. (1973). Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis. Eur J Pharmacol 23:74-81.
14. Hattori Y, Kawasaki H, Abe K, Kanno M. (1991). Superoxide dismutase recovers altered endotheliumdependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094.
15. 2+ entry through conductive pathway modulates receptor mediated increase in microvessel permeability. Am J Physiol 271:H2377-H2387.
16. Hsueh WA, Anderson PW. (1992). Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 20:253-263.
17. Johnson PC, Brendel K, Meezan E. (1982). Thickened cerebral cortical capillary basement membranes in diabetes. Arch Pathol Lab Med 106:214-217.
18. Joyner WL, Mayhan WC, Johnson RL, Phares CK. (1981). Microvascular alterations develop in syrian hamsters after the induction of diabetes mellitus by streptozotocin. Diabetes 30:93-100.
19. Knudsen GM, Jakobsen J, Barry DI, Compton AM, Tomlinson DR. (1989). Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience 29:773-777.
20. Llorach MAS, Bolim GM, Garcia-Leme J. (1976). Decreased vascular reactions to permeability factors in experimental diabetes. Br J Exp Path 57:747-754.
21. Mathison R, Davison JS. (1993). Altered vascular permeability responses to substance P in diabetic rats: Interactions with a nitric oxide synthiesis inhibitor. Eur J Pharmacol 240:163-168.
22. Mayhan WG. (1992). Role of nitric oxide in modulating permeability of the banister cheek pouch in response to adenosine 5-'diphosphate and bradykinin. Inflammation 16:295-305.
23. Mayhan WG. (1993). Cerebral circulation during diabetes mellitus. Pharmacol Therap 57:377-391.
24. 4-induced increases in microvascular transport. Am J Physiol 265:H409-H414.
25. Mayhan WG. (1994). Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol 266:H2369-H2373.
26. Mayhan: WG, Joyner WL. (1984). The effect of altering the external calcium concentration and a calcium channel blocker, verapamil, on microvascular leaky sites and dextran clearance in the hamster cheek pouch. Microvasc Res 28:159-179.
27. Mayhan WG, Sahagun G, Spector H, Heistad DD. (1986). Effects of leukotriene C4 on the cerebral microvasculature. Am J Physiol 251:H471-H474.
28. Mayhan WG, Simmons LK, Sharpe GM. (1991). Mechanism of impaired responses of cerebral artcriolcs during diabetes mellitus. Am j Physiol 260: H319-H326.
29. Murray MA, Heistad DD, Mayhan WG. (1991). Role of protein kinase C in bradykinin-induced increases in microvascular permeability. Circ Res 68:1340-1348.
30. Nathan DM. (1993). Long-term complications of diabetes mellitus. New Eng J Med 328:1676-1685.
31. Ohishi K, Carmines PK. (1995). Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 5: 1559-1566.
32. Parving H. (1976). Increased microvascular permeability to plasma proteins in short- and long-term juvenile diabetes. Diabetes 25:884-889.
33. Phares CK. (1980). Streptozotoein-induced diabetes in Syrian hamsters: New model of diabetes mellitus. Experientia 36:681-682.
34. Pieper GM, Gross GJ. (1988). Oxygen free radicals abolish endothelium dependent relaxation in diabetic rat aorta. Am J Physiol 255:H825-H833.
35. Pieper GM, Gross GJ. (1991). Endothelial dysfunction in diabetes. In Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. (GM Rubanyi Ed.) Futura Publishing. Mount Kisco, NY. 223-249.
36. Pieper GM, Langenstroer P, Cross GJ. (1993). Hydroxyl radicals mediate injury to endotheliumdependent relaxation in diabetic rat. Mol Cell Biochem 122:139-145.
37. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST. (1992). Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol Heart Circ Physiol 263:H676-H680.
38. Pieper GM, Peltier BA. (1995). Amelioration by Larginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovase Pharmacol 25:397-403.
39. Svensjo E. (1978). Bradykinin and prostaglandin El, E2, and F2 alpha induced macromolecular leakage in the hamster cheek pouch. Prostaglandins and Medicine 1:397-410.
40. Svensjo E. (1978). Characterization of leakage of macromolecules in postcapillary venules. Acta Universitatis Upsaliensis 34:1-42.
41. Taylor PD, Poston L. (1994). The effect of hyperglycemia on function of rat isolated mesenteric resistance artery. Br J Pharmac 113:80-808.
42. Taylor PD, Wickenden AD, Mirrlees DJ, Poston L. (1994). Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin induced diabetes: Effect of treatment with the aldose reductase inhibitor, ponalrestat. Br J Pharmac 111: 42-48.
43. Tesfamariam B. (1994). Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol Med 16: 383-391.
44. Tesfamariam B, Cohen RA. (1992). Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol Heart Circ Physiol 263:11321-H326.
45. Tesfamariam B, Jakubowski JA, Cohen HA. (1989). Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol 257: H1327-H1333.
46. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR. (1993). Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232.
47. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. (1992). Functional consequences of streptozotocininduced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44:103-150.
48. Tooke JE. (1989). Microcirculation and diabetes. Brit Med Bull 45:206-223.
49. Yong T, Mayhan WG. (1992). Effect of prostaglanin E 1 on leukotrieue C4-induced increases in vascular permeability of hamster cheek pouch. Inflammation 16:159-167.
50. Yuan Y, Granger HJ, Zawieja DC, Chilian WM. (1992). Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am J Physiol Heart Circ Physiol 263:H1641-H1646.
51. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. (1993). Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol Heart Circ Physiol 264:H1734-H1739.